Iceland Genomics Announces Research Agreement With Roche

Iceland Genomics (IGC), a privately held company, and Roche Diagnostics, Basel, Switzerland, entered into a cancer biomarker discovery collaboration. IGC and Roche Diagnostics will jointly analyze patient samples to validate novel molecular markers for diagnostic tests to predict recurrence of cancer for selected tumor entities.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/03-17-2005/0003204173&EDATE=)

(http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/03-17-2005/0003204173&EDATE=)